Amaroq Therapeutics

Nothing remains concealed. Exploring long #noncoding #RNAs in #cancer. Founded by @oncogenie

[Amaroq Therapeutics @amaroqtx]

We are honored to be featured in the top 5 of NZ's hottest biotech startups! Big thanks to @businessdesk_nz

https://t.co/t0C4metzIQ

[Amaroq Therapeutics @amaroqtx]

Thanks so much for including us in this panel!
#QRW2023

[Tim Woodfield @Tim_WoodfieldNZ]

Great to moderate the Research Commercialisation workshop @QTResearchWeek supported by @otago Centre for Bioengineering with expert panel: Sarah Diermeier @amaroqtx Elliot Dunn #brandoncapital Kathleen Lucere #EvenCapital Sam Wilkins @OtagoInnovation Azam Ali @otago @MedtechNZ

[Amaroq Therapeutics @amaroqtx]

Exciting updates on AURORA our oncology target ID platform!

Check out our webpage and LinkedIn for details https://t.co/FmyLLddBdH

[Riya Palchaudhuri @riyapalc]

Interesting talk by Sarah Diermeier from @amaroqtx on developing a new class of therapeutics that target long non-coding RNAs in cancer
#ShineDalgarnoCentre #ANURNA2023 #SDCRI @JCSMR

[Barbara Uszczynska-Ratajczak @buszczynska]

An absolutely brillant talk from @oncogenie at #EMBOnoncodingRNA @amaroqtx

[Amaroq Therapeutics @amaroqtx]

Great to see our Founder and CSO Sarah Diermeier featured for #WomensHistoryMonth in @NatureBiotech!

[Nature Biotechnology @NatureBiotech]

For #WomensHistoryMonth, we're celebrating outstanding scientists in the biotech industry. We salute Sarah Diermeier, founder and chief scientific officer of Amaroq Therapeutics, which is focused on developing a new class of therapeutics that target long non-coding RNAs in cancer

[Amaroq Therapeutics @amaroqtx]

As another recent addition to the team, we are welcoming @KLucere!
Kat comes with a deep tech background (cancer research and neurobiology) in both US and NZ science ecosystems. She is now doing a stellar job supporting our BD efforts.

We are so excited to have you Kat!

[Dr. Megan O'Malley @MMROMalley]

So excited to have joined the team and be working on this amazing technology!

[Dr. Megan O'Malley @MMROMalley]

Grateful to have had the opportunity to attend and present my research at #cshlcancer22 this past week.
Met some amazing people, heard about fantastic science and ofc the highlight was the famous CSHL lobster!! 🦞

[Amaroq Therapeutics @amaroqtx]

@MMROMalley Great to hear you enjoyed the meeting (and lobster) @CSHL!

[Amaroq Therapeutics @amaroqtx]

We made some recent additions to our team!

We were lucky to recruit the amazing @MMROMalley, an RNA Tx and oncology expert, to lead our in vitro TIDVAL efforts.
Welcome Meg, we look forward to developing the next generation of cancer drugs together!

[Dr. Sarah Diermeier @oncogenie]

Join us next Monday at a @BIOTechNZ event in Dunedin!

I‘ll be speaking about @amaroqtx alongside the CEO of @PacificEdgeLtd and others in the local biotech sphere

[Amaroq Therapeutics @amaroqtx]

We are thrilled to announce our recent progress towards the next generation of RNA therapeutics in oncology.

We were also fortunate to assemble a stellar Scientific Advisory Board that will guide us on our path to the clinic!

https://t.co/Q1MScJREJe

[Amaroq Therapeutics @amaroqtx]

R&D team photo with our Operations Manager Dr Nadine Brew (right), who visited us this week from Melbourne.

Had two productive days of strategic planning to map out the next 12 month’s of our RNA therapeutics development program. Exciting times ahead!

[Amaroq Therapeutics @amaroqtx]

Experience in RNA biology and/or drug development is preferred

[Amaroq Therapeutics @amaroqtx]

We have some exciting job opportunities coming up🤩

If you are keen to develop the next generation of RNA therapeutics for oncology, please get in touch!

[Otago Biochemistry @OtagoBiochemist]

Research leader pushes nanomedicine hub in NZ https://t.co/mGaVuTmKiO

New Zealand should become a nanomedicine production hub, says an up-and-coming commercial researcher based here at Otago Biochemistry.

Dr Sarah Diermeier, Rutherford Discovery Fellow and senior lecturer, ma…

[Dr. Sarah Diermeier @oncogenie]

Oped by myself and the brilliant Kylie Price, CTO of @Malaghan_Inst on how recent technological advancements in mRNA vaccines and the RNA therapeutics space can benefit the NZ economy

https://t.co/CFw4y1v6xv

[Amaroq Therapeutics @amaroqtx]

Huge congrats to @allPowerde!!

[AEHRC @ehealthresearch]

Here's what @allPowerde had to say about winning the AI in Innovation award at last night's @women_in_ai awards. 🏆🥳

#cloudcomputing #cloud #AI

[Amaroq Therapeutics @amaroqtx]

Fantastic collaboration with @allPowerde @ehealthresearch!

[AEHRC @ehealthresearch]

A great story about how we boosted product confidence of a world-leading #RNA therapeutics start-up, @amaroqtx.
#healthdata #PrecisionMedicine #CancerResearch

https://t.co/nG9L44rvVd
@TBioinf @allPowerde

[Gene Yeo’s Lab at UC San Diego @yeo_lab]

Excited to share that Eclipsebio (co-founded by our lab alums @EVanNostrandLab and Alex Shishkin) announces a $14 Million Series A Financing to Advance Its RNA Genomics Technology Platform https://t.co/IUei4m6CrY